Kriya Therapeutics appoints Indian American Neera Ravindran as chief financial officer
Prior to joining Kriya Therapeutics, Neera Ravindran worked at Vir Biotechnology as Vice President and Head of Investor Relations.
Neera Ravichandran has been named chief financial officer at Kriya Therapeutics, a Redwood City, California-based firm that is a pioneering breakthrough technology and therapeutics in gene therapy.
The company's primary goal is to change how gene treatments are produced and manufactured.